DAZAP1

Across TCGA pan-cancer cohorts, DAZAP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DAZAP1 data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher DAZAP1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated DAZAP1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LSCC show a favorable association.

LUAD, CCRCC, and HNSC are the cancer types where DAZAP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Quartile	All	0.944	0.677	.006	31	view →
CCRCC	DFS	Median	All	0.708	0.900	.005	12	view →
HNSC	DFS	Median	III,IV	0.916	0.988	.041	2	view →
LSCC	DFS	Tertile	II,III,IV	0.815	0.550	.047	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DAZAP1–LUAD (OS)

Open the LUAD breakdown →